首页 > 市场调查报告书 > 製药

药物开发临床实验开发业务受託机关

市场调查报告书

商品编码

1609872

2025-2033 年日本临床前 CRO 市场报告（按服务（生物分析和 DMPK 研究、毒理学测试等）、最终用途（生物製药公司、政府和学术机构、医疗器材公司）和地区

Japan Preclinical CRO Market Report by Service (Bioanalysis and DMPK Studies, Toxicology Testing, and Others), End Use (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 116 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年，日本临床前 CROIMARC Group规模达到 2.432 亿美元。由于公司更加重视其核心优势以及最近在专业治疗方面的突破，市场正在见证巨大的发展势头。

临床前合约研究组织 (CRO) 是一家为生物技术、製药和医疗器材领域提供多样化研发 (R&D) 服务的公司。这些服务涵盖广泛，包括毒理学研究、药物动力学评估、製剂开发、监管协助和药效研究。临床前CRO服务的应用涵盖多个领域，包括药物发现、医疗器材评估、生物相容性评估、疾病建模、安全药理学研究以及合适剂型的选择。这些服务有助于加速产品开发、加强对监管要求的遵守、利用专业知识、优化资源分配并提供灵活的研究解决方案。

日本临床前CRO市场趋势：

在日本市场背景下，企业越来越重视专注于发展自己的核心竞争力。这一趋势正在推动对临床前合约研究组织(CRO) 的需求，因为它们使公司能够委託专门的临床前任务，从而使他们能够将更多资源分配到其主要关注领域，例如后期临床试验或行销工作。此外，日本对临床前 CRO 服务的需求激增与新兴经济体製药业的快速扩张有关，而新兴经济体的製药业需要解决独特的医疗保健挑战并满足不断增长的患者群体的需求。此外，市场受益于个人化医疗、生物製剂和基因疗法等专业治疗的最新进展，这需要精确而细緻的临床前测试。此外，临床前 CRO 的广泛采用是出于采用风险平衡方法的愿望，特别是考虑到药物开发的高失败率。最后，在成功执行临床前研究中发挥关键作用的尖端技术的引入预计将在预测期内提振日本市场的成长前景。

日本临床前CRO市场细分：

服务洞察：

生物分析和 DMPK 研究
毒理学测试
其他的

最终用途见解：

生物製药公司
政府和学术机构
医疗器材公司

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本临床前 CRO 市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本临床前 CRO 市场有何影响？
日本临床前CRO市场以服务为基础的细分是怎样的？
日本临床前 CRO 市场以最终用途划分是怎样的？
日本临床前CRO市场价值链的各个阶段是什么？
日本临床前CRO的关键驱动因素与挑战是什么？
日本临床前CRO市场的结构如何？
日本临床前CRO市场的竞争程度如何？

本报告回答的关键问题：

日本临床前 CRO 市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本临床前 CRO 市场有何影响？
日本临床前CRO市场以服务为基础的细分是怎样的？
日本临床前 CRO 市场以最终用途划分是怎样的？
日本临床前CRO市场价值链的各个阶段是什么？
日本临床前CRO的关键驱动因素与挑战是什么？
日本临床前CRO市场的结构如何？
日本临床前CRO市场的竞争程度如何？

生物製药公司
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
政府和学术机构
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
医疗器材公司
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本临床前 CRO 市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 9 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 10 章：日本临床前 CRO 市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 11 章：附录

简介目录

Product Code: SR112024A18712

Japan preclinical CRO market size reached USD 243.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 539.9 Million by 2033, exhibiting a growth rate (CAGR) of 8.3% during 2025-2033. The market is witnessing significant momentum due to a heightened emphasis among companies on their core strengths and recent breakthroughs in specialized treatments.

A preclinical contract research organization (CRO) is a company that delivers diverse research and development (R&D) services to the biotechnology, pharmaceutical, and medical device sectors. These services encompass a wide spectrum, including toxicology investigations, pharmacokinetic assessments, formulation development, regulatory assistance, and pharmacodynamic studies. The applications of preclinical CRO services span various domains, encompassing drug discovery, medical device evaluation, biocompatibility assessments, disease modeling, safety pharmacology investigations, and the selection of appropriate dosage forms. These services facilitate the acceleration of product development, bolster compliance with regulatory requirements, tap into specialized expertise, optimize resource allocation, and offer flexible research solutions.

Japan Preclinical CRO Market Trends:

In the context of the Japanese market, there is an increasing emphasis among companies on concentrating their efforts on their core competencies. This trend is driving the demand for preclinical contract research organizations (CROs) as they enable companies to delegate specialized preclinical tasks, allowing them to allocate more resources to their primary areas of focus, such as late-phase clinical trials or marketing endeavors. Moreover, the surging demand for preclinical CRO services in Japan is linked to the rapid expansion of the pharmaceutical sector in emerging economies, driven by the need to address unique healthcare challenges and cater to a growing patient population. Additionally, the market is benefiting from recent advancements in specialized treatments like personalized medicine, biologics, and gene therapies, which necessitate precise and nuanced preclinical testing. Furthermore, the widespread adoption of preclinical CROs is driven by the desire to adopt a risk-balanced approach, especially in light of the high failure rate in drug development. Lastly, the introduction of cutting-edge technologies that play a pivotal role in the successful execution of preclinical studies is expected to bolster the market's growth prospects in Japan over the forecasted period.

Japan Preclinical CRO Market Segmentation:

Service Insights:

Bioanalysis and DMPK Studies
Toxicology Testing
Others

End Use Insights:

Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan preclinical CRO market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan preclinical CRO market?
What is the breakup of the Japan preclinical CRO market on the basis of service?
What is the breakup of the Japan preclinical CRO market on the basis of end use?
What are the various stages in the value chain of the Japan preclinical CRO market?
What are the key driving factors and challenges in the Japan preclinical CRO?
What is the structure of the Japan preclinical CRO market and who are the key players?
What is the degree of competition in the Japan preclinical CRO market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Preclinical CRO Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Preclinical CRO Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Preclinical CRO Market - Breakup by Service

6.1 Bioanalysis and DMPK Studies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Toxicology Testing
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Others
- 6.3.1 Historical and Current Market Trends (2019-2024)
- 6.3.2 Market Forecast (2025-2033)

7 Japan Preclinical CRO Market - Breakup by End Use

7.1 Biopharmaceutical Companies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Government and Academic Institutes
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Medical Device Companies
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Preclinical CRO Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 Company A
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Company B
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Company C
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Company D
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Company E
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events

10 Japan Preclinical CRO Market - Industry Analysis

10.1 Drivers, Restraints, and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis